Retinoic Acid-Containing Liposomes for the Induction of Antigen-Specific Regulatory T Cells as a Treatment for Autoimmune Diseases
Open Access
- 17 November 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (11) , 1949
Abstract
The current treatment of autoimmune and chronic inflammatory diseases entails systemic immune suppression, which is associated with increased susceptibility to infections. To restore immune tolerance and reduce systemic side effects, a targeted approach using tolerogenic dendritic cells (tolDCs) is being explored. tolDCs are characterized by the expression of CD11c, the major histocompatibility complex (MHC)II and low levels of co-stimulatory molecules CD40 and CD86. In this study, tolDCs were generated using a human-proteoglycan-derived peptide (hPG) and all-trans retinoic acid (RA). RA-tolDCs not only display a tolerogenic phenotype but also can induce an antigen-specific regulatory T cell (Treg) response in vitro. However, further analysis showed that RA-tolDCs make up a heterogeneous population of DCs, with only a small proportion being antigen-associated tolDCs. To increase the homogeneity of this population, 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG)-containing liposomes were used to encapsulate the relevant antigen together with RA. These liposomes greatly enhanced the proportion of antigen-associated tolDCs in culture. In addition, in mice, we showed that the liposomal co-delivery of antigen and RA can be a more targeted approach to induce antigen-specific tolerance compared to the injection of RA-tolDCs, and that these liposomes can stimulate the generation of antigen-specific Tregs. This work highlights the importance of the co-delivery of an antigen and immunomodulator to minimize off-target effects and systemic side effects and provides new insights in the use of RA for antigen-specific immunotherapy for autoimmune and chronic inflammatory diseases.Keywords
Funding Information
- ReumaNederland (LLP-28)
- Health Holland (LSHM18056-SGF)
This publication has 40 references indexed in Scilit:
- Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cellsSelf/Nonself, 2010
- Overview of the immune responseJournal of Allergy and Clinical Immunology, 2010
- LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cellsJournal of Leukocyte Biology, 2008
- All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulationJournal of Experimental Medicine, 2007
- Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acidJournal of Experimental Medicine, 2007
- A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanismJournal of Experimental Medicine, 2007
- Differential Antigen Processing by Dendritic Cell Subsets in VivoScience, 2007
- Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activationJournal of Autoimmunity, 2005
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- The CD8α+ Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated AntigensJournal of Experimental Medicine, 2002